Maria Rezvova

Ms. Maria Rezvova


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MRMaria Rezvova
Maria Rezvova
KKKirill Yu Klyshnikov
Kirill Yu Klyshnikov
AGAleksandr Gritskevich
Aleksandr Gritskevich
Evgeny OvcharenkoEvgeny Ovcharenko
Evgeny Ovcharenko
The development of a novel artificial heart valve with outstanding durability and safety has remained a challenge since the first mechanical heart valve entered the market 65 years ago. Recent progress in high-molecular compounds opened new horizons in overcoming major drawbacks of mechanical and tissue heart valves (dysfunction and failure, tissue degradation, calcification, high immunogenic potential, and high risk of thrombosis), providing new insights into the development of an ideal artificial heart valve. Polymeric heart valves can best mimic the tissue-level mechanical behavior of the native valves. This review summarizes the evolution of polymeric heart valves and the state-of-the-art approaches to their development, fabrication, and manufacturing. The review discusses the biocompatibility and durability testing of previously investigated polymeric materials and presents the most recent developments, including the first human clinical trials of LifePolymer. New promising functional polymers, nanocomposite biomaterials, and valve designs are discussed in terms of their potential application in the development of an ideal polymeric heart valve. The superiority and inferiority of nanocomposite and hybrid materials to non-modified polymers are reported. The review proposes several concepts potentially suitable to address the above-mentioned challenges arising in the R&D of polymeric heart valves from the properties, structure, and surface of polymeric materials. Additive manufacturing, nanotechnology, anisotropy control, machine learning, and advanced modeling tools have given the green light to set new directions for polymeric heart valves.

22 September 2020 in Polymers
Verified
Journal Article
Open access
PDF file
MRMaria Rezvova
Maria Rezvova
Arseniy E YuzhalinArseniy E Yuzhalin
Arseniy E Yuzhalin
TGTatyana Glushkova
Tatyana Glushkova
MMMiraslau I. Makarevich
Miraslau I. Makarevich
PNPavel Nikishau
Pavel Nikishau
Evgeny OvcharenkoEvgeny Ovcharenko
Evgeny Ovcharenko
In this study, we incorporated carbon nanotubes (CNTs) into poly(styrene-block-isobutylene-block-styrene) (SIBS) to investigate the physical characteristics of the resulting nanocomposite and its cytotoxicity to endothelial cells. CNTs were dispersed in chloroform using sonication following the addition of a SIBS solution at different ratios. The resultant nanocomposite films were analyzed by X-ray microtomography, optical and scanning electron microscopy; tensile strength was examined by uniaxial tension testing; hydrophobicity was evaluated using a sessile drop technique; for cytotoxicity analysis, human umbilical vein endothelial cells were cultured on SIBS–CNTs for 3 days. We observed an uneven distribution of CNTs in the polymer matrix with sporadic bundles of interwoven nanotubes. Increasing the CNT content from 0 wt% to 8 wt% led to an increase in the tensile strength of SIBS films from 4.69 to 16.48 MPa. The engineering normal strain significantly decreased in 1 wt% SIBS–CNT films in comparison with the unmodified samples, whereas a further increase in the CNT content did not significantly affect this parameter. The incorporation of CNT into the SIBS matrix resulted in increased hydrophilicity, whereas no cytotoxicity towards endothelial cells was noted. We suggest that SIBS–CNT may become a promising material for the manufacture of implantable devices, such as cardiovascular patches or cusps of the polymer heart valve.

22 February 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MRMaria Rezvova
Maria Rezvova
PNPavel Nikishau
Pavel Nikishau
MMMiraslau I. Makarevich
Miraslau I. Makarevich
TGTatyana Glushkova
Tatyana Glushkova
KKKirill Yu Klyshnikov
Kirill Yu Klyshnikov
Evgeny OvcharenkoEvgeny Ovcharenko
Evgeny Ovcharenko
Nanocomposites based on poly(styrene-block-isobutylene-block-styrene) (SIBS) and single-walled carbon nanotubes (CNTs) were prepared and characterized in terms of tensile strength as well as bio- and hemocompatibility. It was shown that modification of CNTs using dodecylamine (DDA), featured by a long non-polar alkane chain, provided much better dispersion of nanotubes in SIBS as compared to unmodified CNTs. As a result of such modification, the tensile strength of the nanocomposite based on SIBS with low molecular weight (Mn = 40,000 g mol–1) containing 4% of functionalized CNTs was increased up to 5.51 ± 0.50 MPa in comparison with composites with unmodified CNTs (3.81 ± 0.11 MPa). However, the addition of CNTs had no significant effect on SIBS with high molecular weight (Mn~70,000 g mol−1) with ultimate tensile stress of pure polymer of 11.62 MPa and 14.45 MPa in case of its modification with 1 wt% of CNT-DDA. Enhanced biocompatibility of nanocomposites as compared to neat SIBS has been demonstrated in experiment with EA.hy 926 cells. However, the platelet aggregation observed at high CNT concentrations can cause thrombosis. Therefore, SIBS with higher molecular weight (Mn~70,000 g mol−1) reinforced by 1–2 wt% of CNTs is the most promising material for the development of cardiovascular implants such as heart valve prostheses.

21 August 2024 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
MRMaria Rezvova
Maria Rezvova
EOEvgeny A. Ovcharenko
Evgeny A. Ovcharenko
KKKirill Yu Klyshnikov
Kirill Yu Klyshnikov
TGTatiana V. Glushkova
Tatiana V. Glushkova
AKAlexander E. Kostyunin
Alexander E. Kostyunin
YKYulia A. Kudryavtseva
Yulia A. Kudryavtseva
Percutaneous coronary intervention, a common treatment for atherosclerotic coronary artery lesions, occasionally results in perforations associated with increased mortality rates. Stents coated with a bioresorbable polymer membrane may offer an effective solution for sealing coronary artery perforations. Additionally, such coatings could be effective in mitigating neointimal hyperplasia within the vascular lumen and correcting symptomatic aneurysms. This study examines polymer membranes fabricated by electrospinning of polycaprolactone, polydioxanone, polylactide-co-caprolactone, and polylactide-co-glycolide. In uniaxial tensile tests, all the materials appear to surpass theoretically derived elongation thresholds necessary for stent deployment, albeit polydioxanone membranes are found to disintegrate during the experimental balloon expansion. As revealed by in vitro hemocompatibility testing, polylactide-co-caprolactone membranes exhibit higher thrombogenicity compared to other evaluated polymers, while polylactide-co-glycolide samples fail within the first day post-implantation into the abdominal aorta in rats. The PCL membrane exhibited significant water leakage in the permeability test. Comprehensive evaluation of mechanical testing, bio- and hemocompatibility, as well as biodegradation dynamics shows the advantage of membranes based on and the mixture of polylactide-co-caprolactone and polydioxanone over other polymer groups. These findings lay a foundational framework for conducting preclinical studies on stent configurations in large laboratory animals, emphasizing that further investigations under conditions closely mimicking clinical use are imperative for making definitive conclusions.

1 October 2021 in Macromol
Verified
Journal Article
Open access
PDF file
MMMiraslau I. Makarevich
Miraslau I. Makarevich
PNPavel Nikishau
Pavel Nikishau
IBIvan Berezianko
Ivan Berezianko
TGTatyana Glushkova
Tatyana Glushkova
MRMaria Rezvova
Maria Rezvova
Sergei V KostjukSergei V Kostjuk
Sergei V Kostjuk
The cationic polymerization of isobutylene and its block copolymerization with styrene using DiCumCl/TiCl4/2,6-lutidine initiating system has been studied in open conditions. It was shown that a higher concentration of proton trap is required in open conditions as compared to the glove box technique in order to have good control over molecular weight and polydispersity. Polyisobutylenes with Mn ≤ 50,000 g mol−1 and low polydispersity (Đ ≤ 1.2) were prepared at [Lu] = 12 mM. The synthesis of poly(styrene-block-isobutylene-block-styrene) triblock copolymer (SIBS) in open conditions required the addition of proton trap into two steps, half at the beginning of the reaction and the second half together with styrene. Following this protocol, a series of triblock copolymers with different length of central polyisobutylene block (from Mn = 20,000 g mol−1 to 50,000 g mol−1) and side polystyrene blocks (Mn = 4000 g mol−1–9000 g mol−1) with low polydispersity (Đ ≤ 1.25) were synthesized. High molecular SIBS (Mn > 50,000 g mol−1) with low polydispersity (Đ < 1.3) containing longer polystyrene blocks (Mn > 6000 g mol−1) demonstrated higher tensile strength (~13.5 MPa).

1 January 2021 in Russian Journal of Transplantology and Artificial Organs
Verified
Journal Article
Open access
PDF file
MRMaria Rezvova
Maria Rezvova
Evgeny OvcharenkoEvgeny Ovcharenko
Evgeny Ovcharenko
TGT. V. Glushkova
T. V. Glushkova
YKYu. A. Kudryavtseva
Yu. A. Kudryavtseva
LBL. S. Barbarash
L. S. Barbarash
Calcification of biomaterials used in prosthetic heart valves has been a challenging issue in cardiovascular surgery. The objective of this work is to compare the efficiency of polyvinyl alcohol (PVA) and tannic acid (TA) modification of xenomaterials, pre-stabilized with glutaraldehyde (GA) and ethylene glycol diglycidyl ether (EGDE), in reducing calcification. Analysis of mechanical properties evaluated under uniaxial tension, showed a significant increase in the tensile strength of the test samples compared to the control (unmodified) samples (p < 0.05). Additional treatment of GA-fixed tissue with PVA and TA significantly reduced the amount of calcium in the samples implanted into rats for a 60-day follow-up (p < 0.05). The level of calcification of samples prestabilized with EGDE and treated with PVA and TA did not differ from the control group (p = 0.063). Cumulative analysis of the study results demonstrated that the GA-fixed biomaterial modified with PVA and TA can reduce calcium-binding activity and increase strength. This indicates the prospects for clinical application of the proposed treatment methods. This being said, the issue of long-term body response requires further study of the long-term stability of the modified biomaterial under physiologic blood flow conditions.